Mitesh

MHRA Class 2 Medicines Recall: Clarithromycin 500 mg powder for concentrate for solution for infusion (Hameln Pharma Ltd) Drug alert number: EL(25)A/53 Date issued: 11 December 2025 Hameln Pharma Ltd is recalling certain batches of Clarithromycin 500 mg powder for concentrate for solution for infusion. DMRC reference number: DMRC-37790612 Company name: Hameln Pharma ltd Medicine Details [...]

The post MHRA Class 2 Medicines Recall: Clarithromycin 500 mg powder for concentrate for solution for infusion (Hameln Pharma Ltd) appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the November 2025 concessionary price for Propranolol 40mg tablets: Drug Pack size Price concession Propranolol 40mg tablets 28 £2.28 (previously £1.61) The improved price will apply to prescriptions submitted for payment for [...]

The post Improved price concession for Propranolol 40mg tablets for November 2025 appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Amitriptyline hydrochloride 10mg, 25mg, 50mg tablets (Flamingo Pharma UK Ltd) Drug alert number: EL(25)A/52 Date issued: 10 December 2025 Flamingo Pharma UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information. DMRC reference [...]

The post Class 4 Medicines Defect Notification: Amitriptyline hydrochloride 10mg, 25mg, 50mg tablets (Flamingo Pharma UK Ltd) appeared first on Community Pharmacy England.

As part of our Funding & Reimbursement Shorts  series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on disallowed items. Disallowed items are those that have not been passed for payment by the NHS Business Services Authority (NHSBSA). It is important that pharmacy teams understand what can be done avoid [...]

The post Funding & Reimbursement Shorts: Disallowed items appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Cefalexin 125mg/5ml oral suspension sugar free and Cefalexin 250mg/5ml oral suspension sugar free is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP077 Cefalexin 125mg/5ml oral suspension sugar free and SSP078 Cefalexin 250mg/5ml oral suspension [...]

The post Expiry of SSP077 (Cefalexin 125mg/5ml oral suspension sugar free) & SSP078 (Cefalexin 250mg/5ml oral suspension sugar free) appeared first on Community Pharmacy England.